Targeted sequencing, whole-genome sequencing, and whole-genome bisulfite sequencing showed potential for detecting lung cancer.
Pembrolizumab improved overall survival vs chemotherapy regardless of the programmed death ligand 1 tumor proportion score.
A total of 8 quantitative radiologic features were used to characterize indeterminate screen-detected lung nodules.
Merck initially gained accelerated approval for Keytruda with Alimta and carboplatin in May 2017.
Researchers created a web-based decision tool to facilitate personalized discussions regarding lung cancer screening.
Researchers examined nationwide population-based incidence of lung cancer according to sex, race or ethnic group, age group, birth year, and calendar period of diagnosis.
Bioengineered tracheal and bronchial reconstruction was conducted using stented aortic matrices.
The most eligible smokers were populated in South, which had most screening sites but the low screening rates
Four models were well-calibrated and had higher areas under the curve than 5 models that overestimated lung cancer risk.
Serum CKAP4 levels of lung cancer patients were significantly higher than those of healthy controls.
Prostate and lung cancer expected to emerge as the most common types by 2030.
For clinical stage 1 non-small-cell lung cancer, 21.7% of patients upstaged after 1 week and 31.5% after 8 weeks.
More cancer survivors prescribed 5 or more unique medications, including medications with abuse potential.
Researchers developed an algorithmic approach to diagnosing lung cavitary diseases.
Nivolumab plus ipilimumab linked to better survival in NSCLC with high tumor mutational burden.
Majority of patients say they want to know about even minor consequences of cancer drug substitutions.
Dacomitinib is a pan-human epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor.
Findings based on rates in women vs steady decline seen nationally.
An integrated proteomic classifier accurately identified benign lung nodules when used in patients with a pretest probability of malignancy ≤50%.
Independent predictive factors of lung cancer in chronic obstructive pulmonary disease may include frequency of exacerbations, in addition to airflow obstruction and visual emphysema.
Researchers used data from the Atherosclerosis Risk in Communities Study to assess associations between dietary pattern and pulmonary assessments.
During a 10-year period, there was an increase in the rate of commercially insured patients receiving infused chemotherapy in hospital outpatient departments.
Study examines increased physical activity may lower the risk for several cancers and may be beneficial for improving quality of life.
A CHEST expert panel has released updated guidelines for lung cancer screening.
Patients who underwent lung resections had reduced postoperative complication rates when they participated in preoperative exercise.
Mortality rates are higher after surgery vs stereotactic body radiotherapy for patients with early non-small-cell lung cancer.
Lung cancer screening is more effective and efficient for high-risk individuals.
Younger age and higher body mass index may be positive predictors of progression-free survival in patients with squamous cell carcinoma of the lung.
Lack of insurance correlated with a reduced likelihood of chemotherapy and radiation therapy for small cell lung cancer.